Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imalumab (BAX69) combinations in metastatic colorectal cancer
NCT02448810Phase 2Terminated
- Sponsor
- Takeda
- Start
- Jun 2015
- Primary completion
- Feb 2017
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of imalumab in metastatic colorectal cancer (mCRC), sponsored by Takeda. Started Jun 2015; status: terminated.
02
Drugs
imalumab
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02448810.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448810.